Risk Factors for Developing Skeletal-Related Events in Breast Cancer Patients With Bone Metastases Undergoing Treatment With Bone-Modifying Agents

BACKGROUND. Bone-modifying agents (BMAs) reduce the incidence of skeletal-related events (SREs) and are thus recommended for breast cancer patients with bone metastases. However, the risk factors for SREs during BMA treatment are not well-understood. This study evaluated the number and timing of SRE...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncologist
Asıl Yazarlar: Tanaka, Ryota, Yonemori, Kan, Hirakawa, Akihiro, Kinoshita, Fumie, Takahashi, Naoki, Hashimoto, Jun, Kodaira, Makoto, Yamamoto, Harukaze, Yunokawa, Mayu, Shimizu, Chikako, Fujimoto, Manabu, Fujiwara, Yasuhiro, Tamura, Kenji
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: AlphaMed Press 2016
Konular:
Breast Cancer
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4828119/
https://ncbi.nlm.nih.gov/pubmed/26975863
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0377
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller